- Home
- ONCY vs ICMB Comparison
ONCY vs ICMB Comparison
Compare ONCY & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- ICMB
- Stock Information
- Founded
- ONCY 1998
- ICMB 2012
- Country
- ONCY Canada
- ICMB United States
- Employees
- ONCY N/A
- ICMB N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- ICMB Finance: Consumer Services
- Sector
- ONCY Health Care
- ICMB Finance
- Exchange
- ONCY Nasdaq
- ICMB Nasdaq
- Market Cap
- ONCY 49.1M
- ICMB 41.1M
- IPO Year
- ONCY 1999
- ICMB N/A
- Fundamental
- Price
- ONCY $0.69
- ICMB $2.85
- Analyst Decision
- ONCY Strong Buy
- ICMB
- Analyst Count
- ONCY 4
- ICMB 0
- Target Price
- ONCY $4.33
- ICMB N/A
- AVG Volume (30 Days)
- ONCY 1.4M
- ICMB 36.7K
- Earning Date
- ONCY 07-31-2025
- ICMB 05-13-2025
- Dividend Yield
- ONCY N/A
- ICMB 16.78%
- EPS Growth
- ONCY N/A
- ICMB N/A
- EPS
- ONCY N/A
- ICMB 0.82
- Revenue
- ONCY N/A
- ICMB $20,996,189.00
- Revenue This Year
- ONCY N/A
- ICMB N/A
- Revenue Next Year
- ONCY N/A
- ICMB N/A
- P/E Ratio
- ONCY N/A
- ICMB $3.42
- Revenue Growth
- ONCY N/A
- ICMB N/A
- 52 Week Low
- ONCY $0.33
- ICMB $2.46
- 52 Week High
- ONCY $1.53
- ICMB $3.47
- Technical
- Relative Strength Index (RSI)
- ONCY 69.96
- ICMB 52.61
- Support Level
- ONCY $0.56
- ICMB $2.75
- Resistance Level
- ONCY $0.37
- ICMB $3.00
- Average True Range (ATR)
- ONCY 0.07
- ICMB 0.09
- MACD
- ONCY 0.04
- ICMB 0.01
- Stochastic Oscillator
- ONCY 83.26
- ICMB 58.82
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.